Andrew Tsotinis

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Tissue Engineering

Induced Pluripotent Stem Cells

Structural Basis

Molecular Docking

Top Venues

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew Tsotinis, Pandelis A Afroudakis, Ioannis P Papanastasiou, Aikaterini Sakellaropoulou, Marina Boniakou, Dimitri Komiotis, Peter J Garratt, Philippe Delagrange, Alina Bocianowska-Zbrog, David Sugden
Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6-Dihydroindolo[2,1-a]isoquinolines and Related Systems. ChemMedChem 17 (12) (2022)
Marilena Vlachou, Stefanos Kikionis, Angeliki Siamidi, Sotiria Kyriakou, Andrew Tsotinis, Efstathia Ioannou, Vassilios Roussis
Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide. Pharmaceutics 11 (9) (2019)
Angeliki-Sofia Foscolos, Ioannis P Papanastasiou, Andrew Tsotinis, Martin Craig Taylor, John M Kelly
Synthesis and Evaluation of Nifurtimox-Adamantane Adducts with Trypanocidal Activity. ChemMedChem 14 (13) (2019)
Andrew Tsotinis, Rodanthi Kompogennitaki, Ioannis P Papanastasiou, Peter J Garratt, Alina Bocianowska, David Sugden
Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists. MedChemComm 10 (3) (2019)
Markos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, Andrew Tsotinis, Martin Craig Taylor, John M Kelly
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. brucei. RSC medicinal chemistry 11 (1) (2019)